Generation of a systemic antitumor response with regional intratumoral injections of interferon γ retroviral vector

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2231-2241

  Karavodin, L M ^a   Robbins, J ^b   Chong, K ^c   Hsu, D ^a   Ibanez, C ^a   Mento, S ^d   Jolly, D ^a   Fong, T C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Immusol Inc   (United States)

^c CELGENE CORPORATION   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; FEMALE; GENE THERAPY; INTRATUMORAL DRUG ADMINISTRATION; LUNG INJURY; LUNG WEIGHT; MOUSE; NONHUMAN; RETROVIRUS; SOLID TUMOR; T LYMPHOCYTE; TUMOR VOLUME;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0032505748     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2231     Document Type: Article

References (8)

1. ABDEL-WAHAB, Z.A., OSANTO, S., DARROW, T.L., BARBER, J.R., VERVAERT, C.E., GANGAVALLI, R., McCALLISTER, T.J., and SEIGLER, H.F. (1994). Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. Cancer Gene Ther. 1(3), 171-179.
2. ABDEL-WAHAB, Z., WELTZ, C., PICKETT, N., VERVAERT, C., BARBER, J.R., and SEIGLER, H.A. (1997). Phase I clinical trial of immunotherapy with interferon-gamma gene modified autologous melanoma cells monitoring the humoral immune response. Cancer 80(3), 401-412.
3. ADDISON, C.L., BRACIAK, T., RALSTON, R., MULLER, W.J., GAULDIE, J., and GRAHAM, F.L. (1995). Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. U.S.A. 92, 8522-8526.
4. ALEVIZOPOULOS, A., and MERMOD, N. (1997). Transforming growth factor-beta: The breaking open of a black box. Bioessays 19(7), 581-591.
5. ARMENTANO, D., YU, S.-F., HANTOFF, P.W., VON RUDEN, T., ANDERSON, W.F., and GILBOA, E. (1987). Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61, 1647-1650.
6. BONNEKOH, B., GREENHALGH, D.A., BUNDMAN, D.S., ECKHARDT, J.N., LONGLEY, M.A., CHEN, S.H., WOO, S.L.C., and ROOP, D.R. (1995). Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer. J. Invest. Dermatol. 104, 313-317.
7. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H., and HART, I.R. (1994). systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res. 54, 6228-6234.
8. YUHAS, J.M., and PAZMINO, N.H. (1974). Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. Cancer Res. 34, 2005-2010.